The Subcutaneous Injection of Organophosphate: A Case Report Publisher



Zoofaghari S¹ ; Dehkordi AF¹ ; Nemati K¹ ; Hashemzadeh M^{2, 3} ; Otroshi A¹
Source: International Journal of Medical Toxicology and Forensic Medicine Published:2021

Abstract

Organophosphate (OP) poisoning is prevalent in developing countries. Toxicity occurs by voluntary injection, inhalation, and absorption. Self-injection is rare. The current case report describes a 61-y/o male with subcutaneous self-injected one cc OP poisoning presenting with delayed drowsiness, nausea, and vomiting. He was treated and presented a good clinical response to treatment with pralidoxime and had a successful recovery. Diagnosis of OP compound toxicity by the parenteral route is a challenge. By observing patients, the dose, and the time between poisoning until the time to start treatment, we can conclude different presentations and outcomes of OP poisoning. © 2021 Shahid Beheshti University of Medical Sciences. All rights reserved.